The research interest of our lab is in the field of medicinal chemistry. The primary goal of our research is to develop in vivo pharmacology probes to study novel therapeutic approaches to treat diseases. Currently, we are studying several classes of alkaloids and disulfide containing cyclic peptides. The natural and non-natural products generated are then screened for biological activity in assays related to various therapeutic areas. The lab is also involved in several collaborative projects related to pharmacological probe development. One of these projects aims to design selective inhibitors of inosine-5'-monophosphate dehydrogenase (IMPDH) from the protozoan parasites Cryptosporidium parvum, which are potential bio-warfare agents and major causes of diarrhea and malnutrition. This project also has expanded to include other microorganisms that may be susceptible to selective IMPDH inhibition. Another project aims to design subtype selective inhibitors of activin-like kinase 2 (ALK2). This target has been implicated in a variety of diseases, including bone and cardiovascular diseases. Finally, another project aims to design selective inhibitors receptor interacting kinase 2 and 3 (RIPK2 and RIPK3), which may be involved in a variety of acute and chronic conditions, including inflammatory diseases.
Publications/Creative Works
Click here to search for this faculty member's publications on PubMed.
Important Disclaimer: The responsibility for the accuracy of the information contained on these pages lies with the authors and user providing such information.